David Repke
David B. Repke BSc | |
|---|---|
| Other names | David B. Repke |
| Alma mater | Michigan Technological University (BSc; 1966–1970) |
| Occupation | Medicinal chemist |
| Years active | 1973–2010 |
| Employer(s) | Syntex, Roche |
| Known for | Work in the area of psychedelic tryptamines |
| Notable work | Anadenanthera: Visionary Plant of Ancient South America (2006) |
| Website | www |
David Repke, or David B. Repke, is an American medicinal chemist who has done work in the area of psychedelic drugs. He and his colleagues are known to have been the first to synthesize and describe a number of notable psychedelic tryptamines, including 4-HO-MET, 4-HO-MPT, 4-HO-DPT, 4-HO-DBT, 4-HO-DiPT, MiPT, 4-HO-MiPT, 5-MeO-MiPT, 4-HO-McPeT, and 4-HO-pyr-T, among others. He is known to have collaborated with Alexander Shulgin and Dennis McKenna on scientific work. Repke has also published a book on the entheogenic use of Anadenanthera in South America that was coauthored with Constantino Manuel Torres.